RespireRx Pharmaceuticals Inc (fka RSPI)

[jerrydylan]

Talk to GNVC how to design a pivotal trial in Pancreatic Cancer-they saw some benefit but then some conflicting numbers which busted the stock to an All-time low. I mean that none of it is "easy" but the efficasy is unquestioned in RD. That said , I think the numbers will not match what CX-717 was going to snatch from an ADHD deal, say $50 million upfront plus XX hundreds of millions in milestones-but we'll sell a licensce....I asked a Psychiatric nurse practitioner I know what an effective, non-stimulant, ADHD drug would be worth.... ANSWER: an enormous sum of money, she prescribes an awful lot of Adderall. At TG dinner last night my sister , who is in a supervisor role in corrections, was talking about her job and I asked her if they were seeing a whole lot more drug related crime? Answer:... the fastest growing drug related issue--- is the Abuse and use of Adderall, related to writing prescriptions, falsifying the need for drug and selling the drug in the black market. Now anyone want to think why someone wants CX-717 back in play in Europe, and why CX-1739 with 20 years of patents might have a ton of value?